PMC:7091888 / 16498-16695 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"785","span":{"begin":80,"end":85},"obj":"Gene"},{"id":"795","span":{"begin":13,"end":23},"obj":"Species"},{"id":"796","span":{"begin":46,"end":56},"obj":"Species"},{"id":"814","span":{"begin":97,"end":101},"obj":"CellLine"}],"attributes":[{"id":"A785","pred":"tao:has_database_id","subj":"785","obj":"Gene:59272"},{"id":"A795","pred":"tao:has_database_id","subj":"795","obj":"Tax:2697049"},{"id":"A796","pred":"tao:has_database_id","subj":"796","obj":"Tax:2697049"},{"id":"A814","pred":"tao:has_database_id","subj":"814","obj":"CVCL:0063"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"As expected, SARS-CoV-2 RBD protein inhibited SARS-CoV-2 pseudovirus entry into hACE2-expressing 293T cells in a dose-dependent manner with 50% inhibition concentration (IC50) as low as 1.35 µg/ml."}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T127","span":{"begin":28,"end":35},"obj":"Body_part"},{"id":"T128","span":{"begin":102,"end":107},"obj":"Body_part"}],"attributes":[{"id":"A127","pred":"fma_id","subj":"T127","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A128","pred":"fma_id","subj":"T128","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"As expected, SARS-CoV-2 RBD protein inhibited SARS-CoV-2 pseudovirus entry into hACE2-expressing 293T cells in a dose-dependent manner with 50% inhibition concentration (IC50) as low as 1.35 µg/ml."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T259","span":{"begin":13,"end":21},"obj":"Disease"},{"id":"T260","span":{"begin":13,"end":17},"obj":"Disease"},{"id":"T261","span":{"begin":46,"end":54},"obj":"Disease"},{"id":"T262","span":{"begin":46,"end":50},"obj":"Disease"}],"attributes":[{"id":"A259","pred":"mondo_id","subj":"T259","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A260","pred":"mondo_id","subj":"T260","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A261","pred":"mondo_id","subj":"T261","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A262","pred":"mondo_id","subj":"T262","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"As expected, SARS-CoV-2 RBD protein inhibited SARS-CoV-2 pseudovirus entry into hACE2-expressing 293T cells in a dose-dependent manner with 50% inhibition concentration (IC50) as low as 1.35 µg/ml."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T314","span":{"begin":97,"end":101},"obj":"http://purl.obolibrary.org/obo/CLO_0050894"},{"id":"T315","span":{"begin":97,"end":101},"obj":"http://purl.obolibrary.org/obo/CLO_0051650"},{"id":"T316","span":{"begin":97,"end":101},"obj":"http://purl.obolibrary.org/obo/CLO_0052052"},{"id":"T317","span":{"begin":102,"end":107},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T318","span":{"begin":111,"end":112},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"As expected, SARS-CoV-2 RBD protein inhibited SARS-CoV-2 pseudovirus entry into hACE2-expressing 293T cells in a dose-dependent manner with 50% inhibition concentration (IC50) as low as 1.35 µg/ml."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T78","span":{"begin":28,"end":35},"obj":"Chemical"}],"attributes":[{"id":"A78","pred":"chebi_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"As expected, SARS-CoV-2 RBD protein inhibited SARS-CoV-2 pseudovirus entry into hACE2-expressing 293T cells in a dose-dependent manner with 50% inhibition concentration (IC50) as low as 1.35 µg/ml."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T98","span":{"begin":0,"end":197},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"As expected, SARS-CoV-2 RBD protein inhibited SARS-CoV-2 pseudovirus entry into hACE2-expressing 293T cells in a dose-dependent manner with 50% inhibition concentration (IC50) as low as 1.35 µg/ml."}